Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: 1st Biotherapeutics, Apogenix, Bavarian Nordic, Brii, Everest Medicines, Gracell, Harbour Biomed, Innovent Biologics, Inxmed, Kintor, Moderna, Providence, Radiopharm, Revive, Sorrento, Spikimm, Telix.